- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03234933
Post-Operative Ambulatory Challenge and Exercise (PACE) Trial
April 1, 2020 updated by: Michael T. Jaklitsch, Dana-Farber Cancer Institute
This research study is evaluating the postoperative results in terms of quality of life and functional recovery of elderly patients after cancer surgery.
Study Overview
Detailed Description
This is a pilot study, designed to collect data on steps walked (ambulation) per day of lobectomy patients after surgery.
While the investigators know ambulation improves outcomes after surgery, there is no institutional policy, set of patient goals, or method for deciding which patients require further resources, such as physical therapy.
Data collected will be used to set up a hospital-wide strategy for patients to achieve post-operative ambulation milestones more readily.
Study Type
Interventional
Enrollment (Actual)
27
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Brigham and Women's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients Aged ≥ 18 years
- Who underwent or who will undergo lung resection at Brigham and Women's Hospital (BWH)
- With diagnosis of malignant or benign disease
Exclusion Criteria:
- Patients with baseline immobility (i.e. wheelchair-bound, use of any walking assistance device, or gait alterations)
- Patients with cognitive deficits
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Mobility Tracker
|
Tracking Patient's movements and calories
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Steps Taken
Time Frame: 2 years
|
Number of steps taken by subjects will be recorded on a mobility tracker, starting at the time of admission to the floor and ending at the time of discharge.
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Distance walked
Time Frame: 2 years
|
The distance walked by subjects will be recorded on a mobility tracker, starting at the time of admission to the floor and ending at the time of discharge.
|
2 years
|
|
Number of Calories Burned
Time Frame: 2 years
|
The number of calories burned by subjects will be recorded on a mobility tracker, starting at the time of admission to the floor and ending at the time of discharge.
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 2, 2017
Primary Completion (ACTUAL)
April 1, 2020
Study Completion (ACTUAL)
April 1, 2020
Study Registration Dates
First Submitted
July 27, 2017
First Submitted That Met QC Criteria
July 27, 2017
First Posted (ACTUAL)
August 1, 2017
Study Record Updates
Last Update Posted (ACTUAL)
April 3, 2020
Last Update Submitted That Met QC Criteria
April 1, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 17-152
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.